C4x Discovery Share Discussion Threads

[amaretto1] 07/5/2020 07:18

Look on the bright side It's not a lot ...1 million... is small amount And at 15 ... which is above closing price ...

[seans66] 07/5/2020 07:10

unbelievable! not enough to shaft the Shareholders once but twice in less than 6 months, is beyond taking the p1ss!

[amaretto1] 07/5/2020 07:05

Incredible !!

[the stigologist] 07/5/2020 02:53

Nice accolade for C4XD

30 Rising Leaders in Life Sciences


Bhavna Hunjan
C4X Discovery Holdings PLC
Head of Corporate Strategy and Development

Bhavna Hunjan holds a master’s degree in biochemistry from the University of Oxford. She joined C4X Discovery in 2016 as senior corporate strategy manager before becoming head of corporate strategy and development in 2017. C4X Discovery is an early-stage biotechnology company focused on small molecule drug discovery. At the company, Hunjan is responsible for a number of activities including business strategy, M&A, licensing-focused business development, alliance and partnership deal-making, as well as external strategic communications.

The company’s DNA-based target identification platform Taxonomy3 utilizes human genetic data sets to identify novel patient-specific targets, which it hopes will lead to greater discovery productivity and increased probability of clinical success. Its near-term goal is to drive returns through early-stage revenue-generating deals with the pharmaceutical industry. Its in-house pipeline is primarily focused on inflammation, neurodegeneration and cancer (including immuno-oncology).

Prior to joining C4X, Hunjan was a senior strategy manager at Cancer Research UK, where she led several strategic projects and worked closely with the scientific community.

[the stigologist] 06/5/2020 12:01

Quite easy for anybody to see that from his first posts on this thread what price alloa2003 bought at

Why try to deny facts ?

I guess it must be the 'rampers' at 14p who caused it to collapse ?

[blueblood] 06/5/2020 11:52

You really are a pompous arrogant tw*t on the wrong side of your trades here. Talking the company down is great idea...

[blueblood] 05/5/2020 16:13

Well it's over to BoD now. Must say they seem very laid back and could do with feeling some heat.

[blueblood] 05/5/2020 15:51

OK so what's the recovery story and what timescale? It's fallen a long way to allow BoD in at 15p and they aren't making even in that. Are they proactive or do they just carry on as normal ignoring a changed environment?

[blueblood] 05/5/2020 14:08

How much did you pay for your shares then smartass?

[alloa2003] 05/5/2020 12:18

Ramp ramp ramp ramp

[blueblood] 05/5/2020 11:51

Taking their time it's not as if it's urgent....

[the stigologist] 05/5/2020 11:08

Still ZERO from LifeARC on Tuesday 5th May on covid19 despite saying it would be w/c April 27th

[alloa2003] 05/5/2020 10:08

Do you have a start date for the trial?

[the stigologist] 04/5/2020 20:31

One day closer to start of Orexin trial

[alloa2003] 04/5/2020 10:27

Dont see any mention of C4XD or am I missing something? If so stop spouting your pump and dump rubbish.

[the stigologist] 04/5/2020 09:46

LifeARC announced £16m investment alongside MRC

[alloa2003] 01/5/2020 22:37

Now the INDV comment is feasible but I fear a pump and dump so the mighty Stig can bail out lol

[the stigologist] 01/5/2020 16:54

EVG on a bit of a tear

also an NRF2 pathway stock